IP Library Granted Patent US 7,668,598
Granted Patent B2
US 7,668,598 · App. 11/804,137 · Granted Feb 23, 2010

Method and apparatus for stimulating a nerve of a patient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,668,598
App. No.
11/804,137
Granted
Feb 23, 2010
Kind
B2
Abstract

Single-use electrical leads include a status flag element such as a fuse. The nerve stimulator has a “test mode” that determines a current value for treatment, and a “therapy mode” that administers treatment with the chosen current value. If the fuse in the electrical leads is blown, then the stimulator assumes that the leads have already been used and does not enter therapy mode, and optionally test mode. If the fuse in the electrical leads is intact, then the stimulator assumes that the leads are as yet unused, and allows the user to enter either test mode or therapy mode. The fuse is deliberately blown after a particular amount of time spent in therapy mode. After the fuse is blown, the user may still complete the therapy mode, even though the fuse is non-conducting. Preferably the fuse is electrically isolated from the leads that contact the patient.

Claims (20)

1. A method for stimulating a posterior tibial nerve of a patient, comprising:

determining an initial therapy current level for the patient;

delivering a therapy current to the nerve through a lead set initially expressing a “use” status, the therapy current being initially set to the initial therapy current level; and

changing the lead set to express a “do not use” status within a predetermined time after start of the therapy current delivering step;

wherein the therapy current delivering step extends beyond the changing step.

2. The method of claim 1 wherein the initial therapy current level determining step comprises:

alternately increasing a test current and observing the patient for a physical response;

observing the physical response from the patient;

decreasing the test current to a final test current level; and

setting the initial therapy current level equal to the final test current level.

3. The method of claim 2 , wherein the test current is increased and decreased in increments of 0.5 mA.

4. The method of claim 1 , wherein:

the therapy current delivering step extends for about 30 minutes after start of the of the therapy current delivering step; and

the changing step occurs at about one minute after start of the of the therapy current delivering step.

5. The method of claim 1 , wherein:

the therapy current delivering step extends for about 30 minutes after start of the of the therapy current delivering step; and

the changing step occurs at about two minutes after start of the of the therapy current delivering step.

6. The method of claim 1 , wherein:

the therapy current delivering step extends for about 30 minutes after start of the of the therapy current delivering step; and

the changing step occurs at about five minutes after start of the of the therapy current delivering step.

Assignments (6)
SECURITY INTEREST Recorded Apr 2, 2024
From: CLINICAL INNOVATIONS, LLC; COGENTIX MEDICAL, INC.; UROPLASTY, LLC; GI SUPPLY, INC.; LABORIE MEDICAL TECHNOLOGIES CANADA ULC; LABORIE MEDICAL TECHNOLOGIES CORP.; MEDICAL MEASUREMENT SYSTEMS B.V.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066986/0500 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 12, 2020
From: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
To: COGENTIX MEDICAL, INC.; LABORIE MEDICAL TECHNOLOGIES CANADA ULC; UROPLASTY LLC
Reel/Frame 051906/0518 →
SECURITY INTEREST Recorded Apr 23, 2018
From: COGENTIX MEDICAL, INC.; UROPLASTY LLC; LABORIE MEDICAL TECHNOLOGIES CANADA ULC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 045609/0561 →
MERGER AND CHANGE OF NAME Recorded Apr 20, 2015
From: UROPLASTY, INC.; VISOR MERGER SUB LLC
To: UROPLASTY, LLC
Reel/Frame 035445/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: HERREGRAVEN, MARC M.; SANDSTROM, PAUL EDWARD; SCHAUER, ANTHONY W.
To: UROPLASTY, INC.
Reel/Frame 019971/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: HERREGRAVEN, MARC M.; SANDSTROM, PAUL EDWARD; SCHAUER, ANTHONY W.
To: UROPLASTY, INC.
Reel/Frame 019971/0799 →